argenx SE
IPOargenx | Homepage - Reaching Patients Through Immunology Innovation
Public · Amsterdam, Netherlands · Founded 2008 · $1.1B raised
- Headquarters
- Amsterdam
- Employees
- 501–1000
- Founded
- 2008
- Business Model
- B2B
- Website
- argenx.com
- Total Funding
- $1.1B
- Last Round
- $1.1B Growth EquityJul 2023
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.
About
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Founded in 2008, the company has built an antibody innovation ecosystem where pioneering scientists and antibody engineers work to accelerate the discovery of next-generation immunology medicines. Through its Immunology Innovation Program (IIP), argenx partners with leading academic institutions and biotechs to translate immunology breakthroughs into differentiated therapies, including its approved product VYVGART (efgartigimod alfa). The company operates across the United States, Europe, and Japan, combining deep immunology expertise with a co-creation model to deliver life-changing medicines for patients with conditions such as generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.
Summary
argenx SE is a Biotech company based in Amsterdam, Netherlands, founded in 2008. It has raised $1.1B in total across 1 round, most recently a $1.1B Growth Equity round in Jul 2023. Investors include Forbion Capital Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jul 2023
Sign up to see all 3 events
Funding: Growth Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/argenx-se"><img src="https://indexed.vc/api/badge/company/argenx-se" alt="argenx SE on Indexed.vc" width="260" height="76" /></a>